Volex (AIM: VLX) upgrades FY2026 revenue to at least $1.22bn as AI data centre demand doubles and board eyes Main Market move
Can inhaled nintedanib improve tolerability and adherence in IPF treatment, according to Avalyn Pharma Inc.?
Read More 7 minute read Technology Industry News Docusign (NASDAQ: DOCU) pushes deeper into legal workflow automation with AI contract review launch Docusign launches an AI contract review assistant inside IAM. See what it means for DOCU stock, legal workflows, and enterprise software competition. byVenkateshMarch 25, 2026